What’s new in molecular genetic pathology 2021: solid tumors and NGS panel selection

por Chen, Guoli, Tsang, Patricia C.
Publicado 2021

What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors

por Tsang, Patricia C., Chen, Guoli
Publicado 2022

Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population

por Wang, He, Tsang, Patricia, D’Cruz, Cyril, Clarke, Kevin
Publicado 2014

TIMP-2 Modulates VEGFR-2 Phosphorylation and Enhances Phosphodiesterase Activity in Endothelial Cells

por Lee, Seo-Jin, Tsang, Patricia, Diaz, Tere, Wei, Bei-yang, Stetler-Stevenson, William George
Publicado 2010

Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma

por Tsang, Patricia S, Cheuk, Adam T, Chen, Qing-Rong, Song, Young K, Badgett, Thomas C, Wei, Jun S, Khan, Javed
Publicado 2012

SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc (1) inhibitors

por Phummarin, Narisa, Boshoff, Helena I., Tsang, Patricia S., Dalton, James, Wiles, Siouxsie, Barry 3rd, Clifton E., Copp, Brent R.
Publicado 2016

MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis

por Edwards, Rachel L., Brothers, Robert C., Wang, Xu, Maron, Maxim I., Ziniel, Peter D., Tsang, Patricia S., Kraft, Thomas E., Hruz, Paul W., Williamson, Kim C., Dowd, Cynthia S., John, Audrey R. Odom
Publicado 2017